We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Siemens Healthineers AG | TG:SHL | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.54 | 1.04% | 52.50 | 52.52 | 52.54 | 52.52 | 51.80 | 51.82 | 4,935 | 12:40:35 |
From May 2021 to May 2024
By Joshua Kirby
Siemens Healthineers AG said late Wednesday that its Covid-19 rapid self-test has been cleared for use in the U.S. and should be available there beginning next month.
The German medical-equipment maker said its nasal antigen Clinitest was granted emergency-use authorization by the U.S. Food and Drug Administration.
The test, which can be bought over the counter and self-administered, should be available beginning in January, with production capacity for the U.S. market reaching tens of millions of tests monthly, Siemens Healthineers said.
Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby
(END) Dow Jones Newswires
December 30, 2021 03:39 ET (08:39 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Siemens Healthineers Chart |
1 Month Siemens Healthineers Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
